Maple Rock Capital Partners’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$250M Buy
628,251
+283,451
+82% +$80.7M 4.89% 4
2026
Q1
$59.8M Buy
344,800
+172,100
+100% +$35.3M 1.95% 18
2025
Q4
$44.2M Sell
172,700
-110,600
-39% -$29M 1.46% 22
2025
Q3
$73.7M Buy
283,300
+178,756
+171% +$47M 2.91% 12
2025
Q2
$25.6M Sell
104,544
-7,786
-7% -$1.94M 1.25% 29
2025
Q1
$29.7M Buy
+112,330
New +$30.4M 1.09% 26

Other funds holding HUM

Maple Rock Capital Partners's HUM Position: Q2 2026 in Review

Maple Rock Capital Partners increased its Humana (HUM) stake by 82% in Q2 2026, buying an estimated $80.7M and bringing the position to 628,251 shares worth $250M. The position accounts for 4.89% of the portfolio, ranked #4.

Maple Rock Capital Partners first reported a position in HUM in Q1 2025 and has held it in 6 quarters since. 925 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • Maple Rock Capital Partners held 628,251 shares of Humana worth $250M as of Q2 2026.
  • Maple Rock Capital Partners bought 283,451 Humana shares in Q2 2026, an estimated $80.7M.
  • Humana made up 4.89% of Maple Rock Capital Partners's portfolio in Q2 2026, its #4 holding.
  • Maple Rock Capital Partners first reported a position in Humana in Q1 2025 and has held it in 6 quarters since.
  • 925 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Maple Rock Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.